About Professor Martin

University Expert

Erika G. Martin is an assistant professor of public administration and policy at the Rockefeller College of Public Affairs and Policy, and a fellow at the Nelson A. Rockefeller Institute of Government. As an applied health policy researcher, she uses mixed methods to evaluate issues related to the allocation of scarce public health resources, and the adoption and impact of public health policies. Recent work in HIV policy includes examining the fairness and flexibility of the federal allocation formula for the Ryan White HIV/AIDS Program, interstate variation in state HIV programs, the national budget impact of expanded HIV screening on public programs, the effects of the New York State HIV testing law on epidemic outcomes and resources needs, and how national health reform will affect HIV care across states. At Rockefeller College, Dr. Martin teaches courses in policy analysis and research design. She received her BA from Brown University, her MPH in epidemiology from the University of Michigan, and her PhD in health policy and administration from Yale University.

Recent Media:

• Kane J. Health Reform's Uncertain Impact on HIV Patients. PBS News Hour. June 3, 2013
• Walsh M. Organ Donation Tax Incentives Failing; Report. New York Daily News August 31, 2012.
• Knox R. Tax Breaks for Organ Donors Aren't Boosting Transplant Supply. Shots: NPR's Health Blog. August 31, 2012.
• Crowley C, HIV Test Law Offers Challenge to ERs. Times Union December 2, 2010.

Other Rockefeller College News:

• Assessing the Impact of HIV-Testing Policy Changes: Q & A with Erika G. Martin, Ph.D., M.P.H.
• Faculty Spotlight: Erika Martin discusses major challenges to HIV testing, treatment and care in the U.S.
• Life After the Ban: An Assessment of US Syringe Exchange Programs’ Attitudes About and Early Experiences with Federal Funding
• Rockefeller College's Erika G. Martin Serves on Institute of Medicine Committee Looking at How to Evaluate National HIV Policies
• Rockefeller Experts Consider Healthcare reform

Peer-Reviewed Publications

• Martin EG, Meehan T, Schackman BR. AIDS Drug Assistance Programs: Managers Confront Uncertainty and Need to Adapt as the Affordable Care Act Kicks In. Health Affairs 2013; 32(6): 1063-1071.
   
• Martin EG, Strach P, Schackman BR. The State(s) of Health: Federalism and the Implementation of Healthcare Reform in the Context of HIV Care. Public Administration Review 2013; e-pub ahead of print.
   
• Martin EG, Schackman BR. Updating the HIV Testing Guidelines: A Modest Change with Major Consequences. New England Journal of Medicine 2013; 368(10): 884-886.

• Ghaffarzadegan N, Epstein AJ, Martin EG. Practice Variation and Experiential Learning in Cesarean Delivery: A Data-Based System Dynamics Approach. Health Services Research 2013; 48(2 Pt 2): 713-734.
   
  

• Martin EG, Wang K. Integrating Substance Abuse Treatment into HIV Care: Missed Opportunities in the AIDS Drug Assistance Program JAIDS Journal of Acquired Immune Deficiency Syndromes 2013; 622(4): 421-429.

• Martin EG, Schackman BR. What Does US Health Reform Mean for HIV Clinical Care? JAIDS Journal of Acquired Immune Deficiency Syndromes 2012; 60(1): 72-76.

• Venkataramani AS, Martin EG, Vijayan A, Wellen J. The Impact of State Tax Incentives on Living Organ Donations in the United States. American Journal of Transplantation 2012; 12(8): 2133-40.

• Green TC, Martin EG, Bowman S, Mann M, Beletsky L. One year after lifting the ban on federal funding for syringe exchange and distribution programs: national survey results on the state of programs' applications for and receipt of federal funds. American Journal of Public Health Published 2012; 102(5): e9-e16.

• Martin EG, Barry CL. The adoption of mental health drugs on state AIDS Drug Assistance Program formularies. American Journal of Public Health 101(6): 1103-1109.

• Martin EG, Paltiel AD, Walensky RP, Schackman BR. Expanded HIV screening in the US: what will it cost government discretionary and entitlement programs? A budget impact analysis. Value in Health 2010; 13(8): 893-902.

• Busch SH, Frank RG, Leslie D, Martin A, Rosenheck R, Martin EG, Barry CL. Antidepressants and suicide risk: how did specific information contained in the FDA safety warnings affect treatment pattens in youth? Psychiatric Services 2010;
  61(1): 11-16.

• Martin, EG and PS Keenan. Sticky dollars: inertia in the evolution of federal allocations for HIV care through the Ryan White Program. Publius: The Journal of Federalism 2009; doi: 10.1093/publius/pjp041

• Pinget C, Martin E, Wasserfallen J-B, Humair J-P, Cornuz J. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling. European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 451-455.

• Martin, EG, Pollack HA, Paltiel AD. Fact, fiction, and fairness: resource allocation under the Ryan White CARE Act. Health Affairs 2006; 25: 1103-1112.

• Hofner MC, Python NV, Martin EG, Gervasoni JP, Graz B, Yersin B. Prevalence of victims of violence admitted to an emergency department.Emergency Medicine Journal 2005; 22: 481-485.

• Martin, EG, Warner KE, Lantz PM.Tobacco harm reduction: what do the experts think? Tobacco Control 2004; 13: 123-128.

• Warner KE, Martin EG. The U.S. tobacco control community’s view of the future of harm reduction. Tobacco Control 2003; 12: 383-390.
   
• Rich JD, Martin EG, Macalino GE, Paul RV, Sanford SL, McNamera S, Taylor LE. Pharmacist Support for Selling Syringes Without a Prescription to Injection Drug Users in Rhode Island. Journal of the American Pharmaceutical Association. 2002; 42: S58-S61.

Technical Reports

• Martin E, MacDonald R. A system dynamics-based evaluation of the New York State HIV testing law. Albany, NY: University at Albany, 2012.